Many Patients Are Unhappy With Treatment For Psoriasis

taking medication

Why More Than Half Of Patients Are Unhappy With Medical Treatment For Psoriasis

Many patients are unhappy with their treatment for psoriasis. Did you know that half of all psoriasis and psoriatic arthritis patients are currently dissatisfied with their conventional medical treatments?Is it any wonder, most are just given a prescription for a pharmaceutical drug and little to no attention is given to any potential triggers of their psoriasis. All the focus is on treatment, not on the prevention of any psoriasis flare-ups.

Here are the results of a 2013 study (1), published in the prestigious JAMA Dermatology Journal:

“While various treatment modalities are available for psoriasis and psoriatic arthritis, widespread treatment dissatisfaction exists”.

This most recent study discovered that many psoriasis and psoriatic arthritis patients living in America in particular, are unhappy with their current treatments, and dissatisfaction with the results and unwanted side effects being the two biggest reasons why a large number of psoriasis and psoriatic arthritis patients go untreated or abandon conventional treatment, according to this 2013 study that spanned research based on patients interviewed between 2003 and 2011. Based on data from 5,604 psoriasis patients collected by the National Psoriasis Foundation (NPF), more than 52 percent of patients with psoriasis said that they were not happy with their conventional treatments, and 46 percent of psoriatic arthritis patients also commenting that they too were not happy with their outcomes from treatments. This is most significant, because psoriasis is considered the most prevalent of all the auto-immune diseases affecting more the 7.5 million American patients alone.

1. – Under treatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States Findings From the National Psoriasis Foundation Surveys, 2003-2011 April W. Armstrong, MD, MPH; Andrew D. Robertson, PhD; Julie Wu, BS; Clayton Schupp, PhD; Mark G. Lebwohl, MD. Jama Dermatology, October 2013, Vol 149, No. 10.

Comments on this entry are closed.